Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:absorption |
systemic
|
| gptkbp:activeIngredient |
testosterone
|
| gptkbp:alternativeName |
gptkb:Testim
gptkb:AndroGel |
| gptkbp:approvedBy |
2000s
|
| gptkbp:ATCCode |
G03BA03
|
| gptkbp:contraindication |
gptkb:cancer
prostate cancer |
| gptkbp:form |
topical gel
40.5 mg per pump 50 mg per sachet |
| gptkbp:halfLife |
~24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Testogel
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Besins_Healthcare
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Europe gptkb:United_Kingdom |
| gptkbp:pregnancyCategory |
X
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
transdermal
|
| gptkbp:sideEffect |
hair loss
acne mood changes skin irritation increased red blood cell count |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
male hypogonadism
testosterone replacement therapy |
| gptkbp:bfsParent |
gptkb:Bayer_HealthCare
|
| gptkbp:bfsLayer |
6
|